Toyotaka Kawamata
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in Tokyo.
Journal: International journal of hematology
Published: March 15, 2025
Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.
Journal: BMJ open
Published: June 23, 2024
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Journal: The Lancet. Oncology
Published: February 29, 2024
Clinical and prognostic features of Langerhans cell histiocytosis in adults.
Journal: Cancer science
Published: September 11, 2022
Mechanisms of action and resistance in histone methylation-targeted therapy.
Journal: Nature
Published: July 06, 2022
Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy.
Journal: Japanese journal of infectious diseases
Published: June 29, 2022
Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML.
Journal: Molecular therapy oncolytics
Published: March 23, 2022
Thiamine Deficiency and Neurological Symptoms in Patients with Hematological Cancer Receiving Chemotherapy: A Retrospective Analysis.
Journal: Journal of neurosciences in rural practice
Published: November 05, 2021
Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review.
Journal: Frontiers in oncology
Published: October 22, 2021
Last Updated: 09/26/2026